ceftolozane/tazobactam

5 Critical Biotech Drug Dates and Events for December
24/7 Wall St
Mon, 12/1/14 - 04:45 pm
biotech
Incyte
ruxolitinib
Cubist Pharma
ceftolozane/tazobactam
Biocryst
peramivir
Vertex Pharmaceuticals
Kalydeco
Pozen
PA8140/PA32540
Cubist nears another big antibiotic approval as M&A rumors simmer
Fierce Biotech
Fri, 08/22/14 - 12:50 pm
Cubist
antibiotics
M&A
ceftolozane/tazobactam
Cubist and Durata Heat Up Antibiotic Market
Motley Fool
Tue, 06/24/14 - 09:51 am
Cubist Pharmaceuticals
Durata Therapeutics
antibiotics
Dalvance
Sivextro
ceftolozane/tazobactam
Cubist antibiotic succeeds in late-stage trial, shares rise
Reuters
Mon, 12/16/13 - 09:02 am
ceftolozane/tazobactam
Cubist
antibiotics
intra-abdominal infections